- Presentations
- 2
- Markets
- 1
Bimzelx is a brand of Bimekizumab marketed by UCB, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Bimekizumab
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 160 mg/1 mL injection, 320 mg/2 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Bimzelx 160 mg/1 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
| Bimzelx 320 mg/2 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Bimzelx
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.